Startup Behind AstraZeneca Covid-19 Vaccine Files for U.S. IPO

Vaccitech PLC, spun out of the University of Oxford in 2016, said it plans to use the technology underpinning the vaccine to develop treatments targeting prostate cancer, hepatitis B and human papillomavirus.